Ian Tietjen

9PUBLICATIONS
27CO-AUTHORS
Biologically active moleculesCheminformatics and quantitative structure-activity relationshipsMedical virologyBiomolecular modelling and designNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 18, 2026
Fragment-Based Design of Pseudo-Natural Products, Synthesis, and Evaluation of Their HIV-1 Latency-Reversing Properties.

Solange A Tanyi, Donatus B Eni, Mohamed Abdelsalam

|Aug 29, 2025
Bioassay-guided Isolation of SARS-CoV-2 Viral Entry Inhibitors From the Brown Algae Lobophora variegata Identifies Fucoxanthin as a Selective ACE-2/Spike Inhibitor.

Victoria M Casimir-Montán, Marie L Matos-Hernández, Adrián González-Bravo

|Apr 23, 2025
Ex vivo and in vivo HIV-1 latency reversal by "Mukungulu," a protein kinase C-activating African medicinal plant extract.

Khumoekae Richard, Zhe Yuan, Hsin-Yao Tang

|Sep 03, 2024
Design of novel and highly selective SARS-CoV-2 main protease inhibitors.

Adi N R Poli, Ian Tietjen, Nitesh K Nandwana

|Apr 30, 2024
5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2.

Felicite Majoumo-Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho

|Apr 22, 2024
Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction.

Donatus B Eni, Joel Cassel, Cyril T Namba-Nzanguim

Pageof 2

Frequent Collaborators

5 joint publications

Joseph M Salvino

3 joint publications

Joel Cassel

3 joint publications

Luis J Montaner

3 joint publications

Donatus B Eni